FDA Adverse Event
Death
Summary report: N
ENDEAVOR RX CORONARY STENT SYSTEM
MDR report key: 1671610
·
Received April 28, 2010
Report
- Report Number
- 2953200-2010-00734
- Event Type
- Death
- Date Received
- April 28, 2010
- Date of Event
- November 21, 2009
- Report Date
- April 2, 2010
- Manufacturer
- MEDTRONIC CARDIOVASCULAR GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
(B) (4): EVALUATION RESULTS: STENT THROMBOSIS, DEATH.
Description of Event or Problem · 1
A 3.5MM DIAMETER X 24MM LENGTH ENDEAVOR RX DRUG-ELUTING CORONARY STENT WAS DEPLOYED IN A PT WITH NO ISSUE REPORTED. THE TARGET LESION, LOCATED IN THE LCX # 13-14 WAS DESCRIBED AS NON TORTUOUS WITH NO CALCIFICATION AND 99% STENOSIS AND WAS PREDILATED. HOWEVER, IT WAS REPORTED THAT APPROXIMATELY 4 WEEKS POST IMPLANT, THE PT PRESENTED IN A STATE OF CARDIOPULMONARY ARREST AND DIED ON THE SAME DAY. COMMUNICATION FROM THE FIELD REPORTED THAT WHETHER THE PT PRESENTED STENT THROMBOSIS OR NOT IS UNK; EVEN WHETHER THE CAUSE OF DEATH WAS ASSOCIATED WITH HEART OR NOT IS UNK.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDEAVOR RX CORONARY STENT SYSTEM | NIQ | MEDTRONIC CARDIOVASCULAR GALWAY | NA | 0001043297 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 77 YR | Death | CLOPIDOGREL| ASPIRIN| HEPARIN| CILOSTAZOL |